読書リサーチレーダー投資フレームワーク
ログイン / 新規登録
← 読解に戻る
ニューストピック · 因子策略容量之争重大3 分で読めるDisconfirmAI 編集部

Avramov et al. Find: Highest-Alpha Factor Strategies Have Capacity Under $2 Billion, Profitability Factors Support $33 Billion

Avramov, Bongaerts, Crego, and Kvaerner used NYSE TAQ data from 2010 to 2023 to calculate capacity ceilings for 35 stock anomalies, finding a severe disconnect between alpha rankings and capacity rankings.

2026-11-12 17:33 GMT+8

Quantitative investment literature has long evaluated whether a signal is worth pursuing using metrics such as alpha, the Sharpe ratio, and statistical significance. A new paper by Avramov, Bongaerts, Crego, and Kvaerner introduces an often-overlooked dimension: capacity—the maximum amount of capital a strategy can deploy before transaction costs erode its market-hedged returns. Using NYSE TAQ data from 2010 to 2023, they estimated spreads, price impact, and liquidity replenishment to calculate deployable capital for 35 characteristic-based anomalies and factors one by one.

The core finding is a severe disconnect between alpha rankings and capacity rankings. The two long legs with the highest gross alphas each support less than $2 billion in market-hedged capital, while strategies with significantly lower alpha in profitability and cash flow can support $20 billion to $33 billion. The profit-margin anomaly has roughly two-fifths the alpha of the highest five-day return strategy, yet its capacity is 97 times greater. For anyone actually allocating capital, this means that the most eye-catching signals in backtests are not necessarily the largest economic opportunities.

The differences in capacity stem primarily from price impact, which is driven by two portfolio characteristics: turnover and the liquidity of the underlying stocks. Short-term reversal strategies turn over 1.8 times per month, incurring 1.6% monthly impact costs at a $10 billion scale; the Amihud liquidity strategy hardly turns over (0.12 times per month), but because it holds illiquid stocks, it still incurs 1.2% monthly impact costs at the same scale. The paths differ, but the result is the same: costs eat away at alpha.

ログイン / 新規登録
読書リサーチレーダー投資フレームワーク

The paper also provides a lever with significant practical implications: rebalancing speed. When the adjustment coefficient τ is less than 1, exiting stocks that leave the target quintile does not involve immediate liquidation but rather a gradual reduction over subsequent months. This single change raises the median capacity of positive-capacity factors from $1.5 billion to $21 billion, a thirteenfold increase at the strategy level. The value-weighted machine-learning composite strategy expands its capacity from $177 million to $19 billion without any change to the signal itself. The rank correlation of capacity rankings is 0.93, indicating that slower rebalancing mainly amplifies scale without drastically altering relative ordering.

It is crucial to emphasize that these figures come entirely from the authors' own first-party estimates, based on a specific data window and specific assumptions about market hedging costs, and have not yet been independently replicated. The median factor capacity of $1.53 billion is in the same order of magnitude as the median hedge fund's net asset value of $1.1 billion; this comparison itself serves as a sobering reminder of scale constraints: most factor strategies are not frictionless at institutional sizes.

The practical implication for readers is: before deciding how much to allocate to an anomaly or factor, measure its trading capacity, rather than looking only at backtested returns. The gap between a niche $200 million strategy and a $20 billion institutional strategy is written in the liquidity of the stocks traded and in the speed of rebalancing.

ソース

  • quantpedia.com↗
トピック

因子策略容量之争

在量化投资领域,一个长期存在的误区是将高Alpha(超额收益)等同于高容量(可部署资金规模)。最新研究揭示,alpha最高的因子策略往往容量不足20亿美元,而盈利因子等低Alpha策略却能支撑330亿美元的规模【背景】。Avramov等人利…

5 ステップ1 件更新日 2026-11-17 09:28

経緯

  1. 2018-08-31MSCI的Alighanbari和Doole发表研究,提出通过控制基准倍数、交易规模和再平衡频率来管理因子指数的容量压力。exa.ai ↗
  2. 2019-07-03Robeco的Blitz和Marchesini指出,传统因子指数因集中交易面临严重容量限制,但通过分散交易时间可显著提升容量而不损失绩效。exa.ai ↗
  3. 2026-03-01牛津大学Cartea等人发布论文,提出自下而上的容量约束框架,发现多数异常策略的可实现夏普比率因流动性限制而大幅下降。wp.lancs.ac.uk ↗

未解決の問題

  • 如何在实际投资组合管理中动态调整再平衡频率以最大化容量,同时最小化信号陈旧带来的Alpha损失?
  • Bonacorsi提出的“认证Alpha容量”框架如何具体应用于非正态分布或非线性衰减的真实市场信号?
  • 随着机器学习模型在因子挖掘中的普及,其复杂的交互效应是否会进一步加剧流动性瓶颈和容量限制?
トピック全文を読む →
リサーチを続ける →